Carregant...
Is Left Ventricular Hypertrophy a Modifiable Risk Factor in ESRD
PURPOSE OF REVIEW: Left ventricular hypertrophy (LVH) is common in ESRD and has been advocated as a therapeutic target. We review considerations for targeting LVH as a modifiable risk factor in ESRD. RECENT FINDINGS: Pathologic myocardial changes underlying LVH provide an ideal substrate for the spr...
Guardat en:
| Publicat a: | Curr Opin Nephrol Hypertens |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4266593/ https://ncbi.nlm.nih.gov/pubmed/25295959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNH.0000000000000067 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|